TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction

V. Tirino, R. Camerlingo, K. Bifulco, E. Irollo, R. Montella, F. Paino, G. Sessa, M. V. Carriero, N. Normanno, G. Rocco, G. Pirozzi

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Metastasis is the leading cause of death by cancer. Non-small-cell lung cancer (NSCLC) represents nearly 85% of primary malignant lung tumours. Recent researches have demonstrated that epithelial-to-mesenchymal transition (EMT) plays a key role in the early process of metastasis of cancer cells. Transforming growth factor-β1 (TGF-β1) is the major inductor of EMT. The aim of this study is to investigate TGF-β1's effect on cancer stem cells (CSCs) identified as cells positive for CD133, side population (SP) and non-cancer stem cells (non-CSCs) identified as cells negative for CD133, and SP in the A549 cell line. We demonstrate that TGF-β1 induces EMT in both CSC and non-CSC A549 sublines, upregulating the expression of mesenchymal markers such as vimentin and Slug, and downregulating levels of epithelial markers such as e-cadherin and cytokeratins. CSC and non-CSC A549 sublines undergoing EMT show a strong migration and strong levels of MMP9 except for the CD133 - cell fraction. OCT4 levels are strongly upregulated in all cell fractions except CD133- cells. On the contrary, wound size reveals that TGF-β1 enhances motility in wild-type A549 as well as CD133 + and SP+ cells. For CD133- and SP- cells, TGF-β1 exposure does not change the motility. Finally, assessment of growth kinetics reveals major colony-forming efficiency in CD133+ A549 cells. In particular, SP+ and SP- A549 cells show more efficiency to form colonies than untreated corresponding cells, while for CD133- cells no change in colony number was observable after TGF-β1 exposure. We conclude that it is possible to highlight different cell subpopulations with different grades of stemness. Each population seems to be involved in different biological mechanisms such as stemness maintenance, tumorigenicity, invasion and migration.

Original languageEnglish
Article numbere620
JournalCell Death and Disease
Volume4
Issue number5
DOIs
Publication statusPublished - May 2013

Fingerprint

Epithelial-Mesenchymal Transition
Neoplastic Stem Cells
Transforming Growth Factors
Stem Cells
Side-Population Cells
Population
Neoplasm Metastasis
A549 Cells
Neoplasms
Gastropoda
Vimentin
Cadherins
Keratins
Non-Small Cell Lung Carcinoma
Cause of Death
Down-Regulation
Maintenance
Lung
Wounds and Injuries

Keywords

  • Cancer stem cells
  • Epithelial'mesenchymal transition
  • Migration
  • TGF-β1

ASJC Scopus subject areas

  • Cell Biology
  • Immunology
  • Cancer Research
  • Cellular and Molecular Neuroscience
  • Medicine(all)

Cite this

TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction. / Tirino, V.; Camerlingo, R.; Bifulco, K.; Irollo, E.; Montella, R.; Paino, F.; Sessa, G.; Carriero, M. V.; Normanno, N.; Rocco, G.; Pirozzi, G.

In: Cell Death and Disease, Vol. 4, No. 5, e620, 05.2013.

Research output: Contribution to journalArticle

@article{978a7fe6629040a3ac24d90d09284148,
title = "TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction",
abstract = "Metastasis is the leading cause of death by cancer. Non-small-cell lung cancer (NSCLC) represents nearly 85{\%} of primary malignant lung tumours. Recent researches have demonstrated that epithelial-to-mesenchymal transition (EMT) plays a key role in the early process of metastasis of cancer cells. Transforming growth factor-β1 (TGF-β1) is the major inductor of EMT. The aim of this study is to investigate TGF-β1's effect on cancer stem cells (CSCs) identified as cells positive for CD133, side population (SP) and non-cancer stem cells (non-CSCs) identified as cells negative for CD133, and SP in the A549 cell line. We demonstrate that TGF-β1 induces EMT in both CSC and non-CSC A549 sublines, upregulating the expression of mesenchymal markers such as vimentin and Slug, and downregulating levels of epithelial markers such as e-cadherin and cytokeratins. CSC and non-CSC A549 sublines undergoing EMT show a strong migration and strong levels of MMP9 except for the CD133 - cell fraction. OCT4 levels are strongly upregulated in all cell fractions except CD133- cells. On the contrary, wound size reveals that TGF-β1 enhances motility in wild-type A549 as well as CD133 + and SP+ cells. For CD133- and SP- cells, TGF-β1 exposure does not change the motility. Finally, assessment of growth kinetics reveals major colony-forming efficiency in CD133+ A549 cells. In particular, SP+ and SP- A549 cells show more efficiency to form colonies than untreated corresponding cells, while for CD133- cells no change in colony number was observable after TGF-β1 exposure. We conclude that it is possible to highlight different cell subpopulations with different grades of stemness. Each population seems to be involved in different biological mechanisms such as stemness maintenance, tumorigenicity, invasion and migration.",
keywords = "Cancer stem cells, Epithelial'mesenchymal transition, Migration, TGF-β1",
author = "V. Tirino and R. Camerlingo and K. Bifulco and E. Irollo and R. Montella and F. Paino and G. Sessa and Carriero, {M. V.} and N. Normanno and G. Rocco and G. Pirozzi",
year = "2013",
month = "5",
doi = "10.1038/cddis.2013.144",
language = "English",
volume = "4",
journal = "Cell Death and Disease",
issn = "2041-4889",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction

AU - Tirino, V.

AU - Camerlingo, R.

AU - Bifulco, K.

AU - Irollo, E.

AU - Montella, R.

AU - Paino, F.

AU - Sessa, G.

AU - Carriero, M. V.

AU - Normanno, N.

AU - Rocco, G.

AU - Pirozzi, G.

PY - 2013/5

Y1 - 2013/5

N2 - Metastasis is the leading cause of death by cancer. Non-small-cell lung cancer (NSCLC) represents nearly 85% of primary malignant lung tumours. Recent researches have demonstrated that epithelial-to-mesenchymal transition (EMT) plays a key role in the early process of metastasis of cancer cells. Transforming growth factor-β1 (TGF-β1) is the major inductor of EMT. The aim of this study is to investigate TGF-β1's effect on cancer stem cells (CSCs) identified as cells positive for CD133, side population (SP) and non-cancer stem cells (non-CSCs) identified as cells negative for CD133, and SP in the A549 cell line. We demonstrate that TGF-β1 induces EMT in both CSC and non-CSC A549 sublines, upregulating the expression of mesenchymal markers such as vimentin and Slug, and downregulating levels of epithelial markers such as e-cadherin and cytokeratins. CSC and non-CSC A549 sublines undergoing EMT show a strong migration and strong levels of MMP9 except for the CD133 - cell fraction. OCT4 levels are strongly upregulated in all cell fractions except CD133- cells. On the contrary, wound size reveals that TGF-β1 enhances motility in wild-type A549 as well as CD133 + and SP+ cells. For CD133- and SP- cells, TGF-β1 exposure does not change the motility. Finally, assessment of growth kinetics reveals major colony-forming efficiency in CD133+ A549 cells. In particular, SP+ and SP- A549 cells show more efficiency to form colonies than untreated corresponding cells, while for CD133- cells no change in colony number was observable after TGF-β1 exposure. We conclude that it is possible to highlight different cell subpopulations with different grades of stemness. Each population seems to be involved in different biological mechanisms such as stemness maintenance, tumorigenicity, invasion and migration.

AB - Metastasis is the leading cause of death by cancer. Non-small-cell lung cancer (NSCLC) represents nearly 85% of primary malignant lung tumours. Recent researches have demonstrated that epithelial-to-mesenchymal transition (EMT) plays a key role in the early process of metastasis of cancer cells. Transforming growth factor-β1 (TGF-β1) is the major inductor of EMT. The aim of this study is to investigate TGF-β1's effect on cancer stem cells (CSCs) identified as cells positive for CD133, side population (SP) and non-cancer stem cells (non-CSCs) identified as cells negative for CD133, and SP in the A549 cell line. We demonstrate that TGF-β1 induces EMT in both CSC and non-CSC A549 sublines, upregulating the expression of mesenchymal markers such as vimentin and Slug, and downregulating levels of epithelial markers such as e-cadherin and cytokeratins. CSC and non-CSC A549 sublines undergoing EMT show a strong migration and strong levels of MMP9 except for the CD133 - cell fraction. OCT4 levels are strongly upregulated in all cell fractions except CD133- cells. On the contrary, wound size reveals that TGF-β1 enhances motility in wild-type A549 as well as CD133 + and SP+ cells. For CD133- and SP- cells, TGF-β1 exposure does not change the motility. Finally, assessment of growth kinetics reveals major colony-forming efficiency in CD133+ A549 cells. In particular, SP+ and SP- A549 cells show more efficiency to form colonies than untreated corresponding cells, while for CD133- cells no change in colony number was observable after TGF-β1 exposure. We conclude that it is possible to highlight different cell subpopulations with different grades of stemness. Each population seems to be involved in different biological mechanisms such as stemness maintenance, tumorigenicity, invasion and migration.

KW - Cancer stem cells

KW - Epithelial'mesenchymal transition

KW - Migration

KW - TGF-β1

UR - http://www.scopus.com/inward/record.url?scp=84879375174&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879375174&partnerID=8YFLogxK

U2 - 10.1038/cddis.2013.144

DO - 10.1038/cddis.2013.144

M3 - Article

C2 - 23640462

AN - SCOPUS:84879375174

VL - 4

JO - Cell Death and Disease

JF - Cell Death and Disease

SN - 2041-4889

IS - 5

M1 - e620

ER -